Treatment of Acute Bacterial Sinusitis
For acute bacterial sinusitis, start with amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) for 10-14 days as first-line therapy, reserving amoxicillin-clavulanate and fluoroquinolones for treatment failures or specific high-risk situations. 1
Confirm the Diagnosis Before Prescribing Antibiotics
Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics. 1 Only prescribe antibiotics when bacterial infection is confirmed by one of three patterns: 1
- Persistent symptoms ≥10 days without clinical improvement 1
- Severe symptoms (fever ≥39°C with purulent nasal discharge and facial pain) for ≥3 consecutive days 1
- "Double sickening" - worsening symptoms after initial improvement from a viral upper respiratory infection 1
Do not use purulent nasal discharge color alone to diagnose bacterial sinusitis, as mucus color reflects neutrophils, not bacteria. 1
First-Line Antibiotic Treatment
Standard First-Line Therapy
- Amoxicillin 500 mg twice daily for mild, uncomplicated maxillary sinusitis 1
- Amoxicillin 875 mg twice daily for moderate disease 1
- Treatment duration: 10-14 days or until symptom-free for 7 days 1
When to Use Amoxicillin-Clavulanate as First-Line
Amoxicillin-clavulanate 875 mg/125 mg twice daily is preferred as first-line therapy in these situations: 1
- Recent antibiotic exposure within past 4-6 weeks 1
- Age <2 years or daycare attendance 1
- Areas with high prevalence of β-lactamase-producing H. influenzae or M. catarrhalis 1
- Moderate-to-severe disease 1
The clavulanate component provides coverage against β-lactamase-producing organisms that have become increasingly prevalent. 1
Treatment for Penicillin-Allergic Patients
Non-Severe Penicillin Allergy (Rash, Delayed Reactions)
Second- or third-generation cephalosporins are safe and effective, as the risk of cross-reactivity is negligible: 1
- Cefuroxime-axetil (second-generation cephalosporin) 2, 1
- Cefpodoxime-proxetil (third-generation, superior activity against H. influenzae) 2, 1
- Cefdinir (third-generation, excellent coverage) 1
Severe Penicillin Allergy (Anaphylaxis, Type I Hypersensitivity)
Reserve respiratory fluoroquinolones for documented severe beta-lactam allergy: 1
Do not use azithromycin or other macrolides due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae. 1
Second-Line Treatment for Treatment Failure
If no improvement occurs after 3-5 days of initial antibiotic therapy, reassess the diagnosis and switch antibiotics: 1
If Initial Therapy Was Amoxicillin
Switch to high-dose amoxicillin-clavulanate: 1
- Adults: 875 mg/125 mg twice daily (or 2000 mg/125 mg twice daily for severe cases) 1
- Pediatrics: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1
If Initial Therapy Was Amoxicillin-Clavulanate
Switch to a respiratory fluoroquinolone: 1
- Levofloxacin 500-750 mg once daily for 10-14 days (provides 90-92% predicted clinical efficacy against drug-resistant S. pneumoniae and β-lactamase-producing organisms) 1, 3
- Moxifloxacin 400 mg once daily for 10 days 1
Alternative: Third-generation cephalosporins (cefpodoxime-proxetil or cefdinir) provide superior activity against H. influenzae but have limitations against drug-resistant S. pneumoniae. 1
Treatment Based on Sinusitis Location
Maxillary Sinusitis (Most Common)
- First-line: Amoxicillin or amoxicillin-clavulanate as described above 2, 1
- Symptoms: Unilateral or bilateral infraorbital pain worsening when bending forward, pulsatile, peaking in evening/night 2
Frontal, Ethmoidal, or Sphenoidal Sinusitis
These locations carry high risk of complications and require more aggressive therapy: 2, 1
- Fluoroquinolones (levofloxacin or moxifloxacin) are recommended as first-line therapy due to potential for serious complications 2, 1
- Hospitalization, bacteriological testing, and parenteral antibiotics are indicated if complications are suspected (meningeal syndrome, exophthalmos, palpebral edema, ocular mobility disorders, severe pain preventing sleep) 2
Adjunctive Therapies That Actually Work
Intranasal Corticosteroids (Strongly Recommended)
Intranasal corticosteroids significantly reduce symptoms and should be added to antibiotic therapy: 1, 4
- Mometasone, fluticasone, or budesonide twice daily 1
- Reduces mucosal inflammation, improves symptom resolution, and may decrease antibiotic use 1, 4
- Patients receiving intranasal corticosteroids with antibiotics had significantly greater reduction in headache, facial pain, and congestion compared to antibiotics alone 4
Oral Corticosteroids (Limited Use)
Short-term oral corticosteroids may be reasonable for: 1
- Patients who fail to respond to initial treatment 1
- Marked mucosal edema 1
- Acute hyperalgic sinusitis (severe pain) 1
- Typical regimen: 5 days 1
Never give systemic corticosteroids without antibiotics when bacterial sinusitis is suspected, as this may suppress immune response and allow bacterial proliferation. 1
Supportive Measures
- Analgesics (acetaminophen, NSAIDs) for pain relief 1
- Saline nasal irrigation for symptomatic relief and mechanical removal of mucus 1, 5
- Adequate hydration, warm facial packs, sleeping with head elevated 1
- Decongestants (systemic or topical) may provide symptomatic relief but have limited evidence for efficacy 1
Pediatric Dosing Considerations
- Standard-dose amoxicillin: 45 mg/kg/day in 2 divided doses for uncomplicated disease 1
- High-dose amoxicillin: 80-90 mg/kg/day in 2 divided doses for high-risk children (age <2 years, daycare attendance, recent antibiotic use, areas with high prevalence of resistant S. pneumoniae) 1
- High-dose amoxicillin-clavulanate: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1
- Ceftriaxone 50 mg/kg IM or IV once daily for children unable to tolerate oral medication 1
Critical Pitfalls to Avoid
- Do not prescribe antibiotics for symptoms lasting <7 days unless severe symptoms are present, as most cases are viral 1, 6
- Do not use azithromycin due to resistance rates of 20-25% 1
- Do not use trimethoprim-sulfamethoxazole due to high resistance rates 1
- Do not use clindamycin as monotherapy - it lacks activity against H. influenzae and M. catarrhalis 1
- Reserve fluoroquinolones for treatment failures or severe beta-lactam allergy to prevent resistance development 1
- Reassess patients at 3-5 days - if no improvement, switch antibiotics or re-evaluate diagnosis 1
- Complete the full antibiotic course even after symptoms improve to prevent relapse 1
When to Refer to a Specialist
Refer to otolaryngology when: 1, 5
- Symptoms refractory to two courses of appropriate antibiotics 1
- Recurrent sinusitis (≥3 episodes per year) 1
- Suspected complications (orbital cellulitis, meningitis, severe frontal/ethmoidal/sphenoidal sinusitis) 2, 1
- Need for sinus aspiration/culture in immunocompromised patients 1
- Evaluation for underlying allergic rhinitis, immunodeficiency, or anatomical abnormalities 1, 5